Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy. [PDF]
NPJ Genom Med, 2016 Metastatic basal cell carcinomas are rare malignancies harbouring Hedgehog pathway alterations targetable by SMO antagonists (vismodegib/sonidegib). We describe, for the first time, the molecular genetics and response of a patient with Hedgehog inhibitor-
Ikeda S +8 more
europepmc +2 more sources
Metastatic basal cell carcinoma: case report and review of the literature
Indian Journal of Dermatology, 2020 Basal cell carcinoma (BCC) is the most commonly occurring carcinoma among humans. However, despite their overall frequency, cases of BCC featuring metastases are extremely rare.
Jose-Francisco Millan-Cayetano +6 more
doaj +2 more sources
c-FOS Expression in Metastatic Basal Cell Carcinoma with Spontaneous Basosquamous Transition [PDF]
Acta Dermato-Venereologica, 2023 is missing (Short communication)
Yu Kurokami +4 more
doaj +2 more sources
A case of metastatic basal cell carcinoma treated with continuous PD-1 inhibitor exposure even after subsequent initiation of radiotherapy and surgery. [PDF]
JAAD Case Rep, 2018 BCC: basal cell carcinoma CT: computed tomography PD-1: programmed cell death protein-1 PD-L1: programmed cell death ligand-
Cannon JGD +3 more
europepmc +2 more sources
Metastatic Basal Cell Carcinoma: A Biological Continuum of Basal Cell Carcinoma? [PDF]
Case Reports in Dermatological Medicine, 2012 Basal cell carcinoma (BCC) accounts for 80% of all nonmelanoma skin cancers. Its metastasis is extremely rare, ranging between 0.0028 and 0.55 of all BCC cases. The usual metastasis to lymph nodes, lungs, bones, or skin is from the primary tumor situated
Karaninder S. Mehta +9 more
doaj +3 more sources
Metastatic basal cell carcinoma: Case series and literature review [PDF]
Brazilian Journal of OtorhinolaryngologyObjective: To present a metastatic head and neck basal cell carcinoma (BCC) series treated by a university teaching service between 1993 and 2021. Methods: A review of medical records of 500 patients with high-risk BCC in the head and neck was performed.
Mariana Gonçalves Rodrigues +6 more
doaj +2 more sources
Metastatic Basal Cell Carcinoma With Unusual Molecular Genetics Findings [PDF]
Clinical Case ReportsBasal cell carcinoma (BCC) rarely metastasizes to other parts of the body. When metastasis occurs, it usually involves regional lymph nodes. BCC lesions located in the head and neck region have been shown to spread to cervical lymph nodes.
Noora Al‐Hail +3 more
doaj +2 more sources
Incidental detection of rare metastatic basal cell carcinoma on screening mammography [PDF]
Radiology Case ReportsBasal cell carcinoma (BCC) is the most common nonmelanoma skin cancer but rarely metastasizes, with an estimated metastatic rate of 0.1%. Metastatic spread to axillary lymph nodes is extremely uncommon, and to our knowledge, no prior cases have reported ...
Alexandra DiTommaso, BS +3 more
doaj +2 more sources
Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease
European Journal of Cancer, 2014 PURPOSE This review provides a description of the epidemiology and survival outcomes for cases with metastatic basal cell carcinoma (mBCC) based on published reports (1981-2011).
Nicole Basset-Seguin +2 more
exaly +2 more sources
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma [PDF]
npj Precision OncologyWe report the basal cell cancer (BCC) cohort of the SWOG/NCI 1609 Dual Anti-CTLA-4 & Anti-PD-1 blockade in Rare Tumors (DART), a phase II prospective, multicenter basket trial of nivolumab and ipilimumab. The primary endpoint was objective response rate (
Sandip P. Patel +17 more
doaj +2 more sources